Vimarsana
Biggest News Aggregation in the World

Progenitor Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Progenitor Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Progenitor Cells Today - Breaking & Trending Today

Anger damages blood vessel function, raising heart disease risk - Vimarsana News

Anger damages blood vessel function, raising heart disease risk

A recent study in the Journal of the American Heart Association reveals that provoked anger, but not sadness or anxiety, acutely impairs endothelial function, shedding light on the link between anger and cardiovascular events.

Unlocking the secrets of long-lived hematopoietic stem cells - Vimarsana News

Unlocking the secrets of long-lived hematopoietic stem cells

Nothing lives forever, but compared to other cells in the body, hematopoietic stem cells (HSCs) are remarkably long-lived. HSCs are blood-forming cells – they give rise to rapidly dividing progenitor cells, which in turn generate hundreds of billions of cells to fulfill the daily demand of oxygen-delivering red blood cells, disease-fighting white blood cells and clot-forming platelets.

Deciphering the role of Th2-multipotent progenitor cells in chronic allergic inflammation - Vimarsana News

Deciphering the role of Th2-multipotent progenitor cells in chronic allergic inflammation

Currently, most therapies for allergic diseases require lifelong treatment. Allergic reactions, characterized by ongoing (type 2) inflammation in response to chronic antigen exposure, underlie many chronic diseases in humans, including asthma, atopic dermatitis, ulcerative colitis and more.

Study finds interleukin-24 enhances CAR-T cell therapy's effectiveness against cancer stem cells - Vimarsana News

Study finds interleukin-24 enhances CAR-T cell therapy's effectiveness against cancer stem cells

The effect of Interleukin-24 (IL-24) on CSCs and CAR-T cell therapy.

Tiny device could help improve safety, effectiveness of cell therapy for spinal cord injury patients - Vimarsana News

Tiny device could help improve safety, effectiveness of cell therapy for spinal cord injury patients

A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.